Severe pre-eclampsia and eclampsia are serious
complications of pregnancy, with around
5/1000 maternities in the UK suffering severe pre-eclampsia0501 and 5/10
000 maternities suffering eclampsia.9401 In
eclampsia, the case fatality rate has been reported as 1.8% and a
further 35% of women experience a major
complication.9401 The Confidential Enquiries into Maternal Deaths
persistently show substandard care in a significant
percentage of the deaths.cem
Defining
pre-eclampsia and eclampsia.
|
Eclampsia is defined as the occurrence of one or more convulsions
superimposed on pre-eclampsia.RCOG
Pre-eclampsia
is pregnancy-induced hypertension in association with proteinuria (> 0.3
g in 24 hours) ± oedema
and virtually any organ system may be affected.
There is consensus
that severe hypertension is confirmed with a diastolic blood pressure ≥
110 mmHg on two occasions or systolic
blood pressure ≥ 170 mmHg on two occasions and that, together with
significant proteinuria (at least 1 g/litre),
this constitutes severe pre-eclampsia. There is less agreement about the
degree of moderate hypertension,
which together with other symptoms or signs constitutes severe pre-eclampsia.
A diastolic blood pressure
≥ 100 mmHg on two occasions and significant proteinuria with at least
two signs or symptoms of imminent
eclampsia will include many women with severe pre-eclampsia, although it
is to be remembered that some
women who present with eclampsia have no prodromal signs.9401 An
important variant of severe pre-eclampsia
is the HELLP syndrome (haemolysis, elevated liver enzymes and low
platelet count).
Clinical features of severe pre-eclampsia (in addition to hypertension
and proteinuria) are:
severe headache
liver tenderness
visual disturbance
platelet count falling to below 100 x 106/l
epigastric pain and/or vomiting abnormal liver enzymes (ALT or AST
rising to above 70 iu/l)
signs of clonus
HELLP syndrome
papilloedema
The Confidential Enquiries reveal that deaths from pre-eclampsia/eclampsia
have been reduced from 11.9/million maternities in 1985–1987 to
7.0/million maternities in 2000–2002, when there were 14 deaths. Nine
women died from cerebral causes, with substandard care in 50% of cases. The Yorkshire series0501 had no deaths in over 1000 cases of
severe pre-eclampsia and eclampsia
and supports the view that a standardised care package for pre-eclampsia
over delivery, with proven
interventions, may reduce the rate of eclampsia.